Content
The 10 Best And Worst Alternative ETFs Of 2017
Article By:
ValueWalk
Read
Monday, January 1, 2018 8:00 AM EDT
When you consider a short VIX ETF made almost 10x times the best non-VIX product, it’s easy to see why people continue to flood into the VIX market.
In this article: XIV(RETIRED)H, SVXY, TVIX, UVXY, XIV(RETIRED), ZIV, MATH, GAA, FTLS, QLS, NAIL, VMIN, DYLS, CWEB
With Stocks At All Time Highs, There Is One Question Traders Can't Answer
Article By:
Tyler Durden
Read
Sunday, December 31, 2017 5:57 PM EDT
There's a vexing question that has stumped most traders: while the cumulative return of the S&P over the past three years, or since 2015, has been an impressive 34%, equity flows over the same period have been consistently negative.
The Next Financial Crisis Will Be Worse Than The Last
Article By:
Nomi Prins
Read
Sunday, December 31, 2017 4:41 PM EDT
Record-setting markets don’t imply economic stability, nor do 40 percent corporate tax cuts translate into 40 percent wage growth. We can march forward into 2018 carrying that knowledge with us.
Top Large-Cap Growth ETFs Of 2017
Article By:
Zacks Investment Research
Read
Sunday, December 31, 2017 4:28 PM EDT
Easy access to cheap money flows resulted in a surging stock market. The combination of these factors has boosted the stock market. This is especially true as growth investing is basically a momentum play and a great strategy in a trending market.
5 Of The Best-Performing Biotech Stocks Of 2017
Article By:
Arpita Dutt
Read
Sunday, December 31, 2017 3:46 PM EDT
2017 turned out to be a pretty good year for the biotech sector. The sector had been struggling due to the drug pricing controversy, mixed results, slower-than-expected new product launches, increasing competition and pipeline setbacks.
4 Large-Cap Pharma Stocks That Outperformed The S&P This Year
Article By:
Zacks Investment Research
Read
Sunday, December 31, 2017 2:53 PM EDT
Upbeat quarterly results, rise in demand on new product sales, successful innovation and product line expansion, strong clinical study results as well as strong performance of legacy products propelled the large-cap drug sector to new highs in 2017.
Housing Market Review (Dec. 2017) – Seasonal Strength Launches With A Flurry Of Activity
The Best Of Pragcap In 2017
Article By:
Cullen Roche
Read
Sunday, December 31, 2017 2:07 PM EDT
With all the amazing sources of financial content out there I know most of you don’t have the time to keep up with everything I write so if I had to narrow this year’s content down to just five posts these would be the ones.
Most-Read Articles From 2017
Article By:
David Templeton
Read
Sunday, December 31, 2017 1:58 PM EDT
One interesting commonality for some of our top posts is the fact the ones focusing on investor sentiment tend to gain higher levels of readership.
Gold's 2018 High: Conservatively 1434, Aggressively 1526
Article By:
Mark Mead Baillie
Read
Sunday, December 31, 2017 1:31 PM EDT
Not only has Gold's price consolidated since the December 2015 low of 1045, but despite seemingly having been stuck forever in the 1200s, it has put in fairly respectable years back-to-back with net gains of 9% in 2016 and now 13% for 2017.
Top 5 Alpha Stories Of 2017
Article By:
AllAboutAlpha
Read
Sunday, December 31, 2017 12:52 PM EDT
We offer, in no particular order, a list of stories that moved us, taking us along with them from Venezuela to Britain and to cyberspace, with a couple of stops in Washington, D.C. along the way.
Small Cap Stocks: Gainers And Losers In 2017
Article By:
Arie Goren
Read
Sunday, December 31, 2017 11:53 AM EDT
Here are the best and the worst performers among Russell 2000 stocks in 2017, and 20 stocks that have a chance to perform well in 2018, which should be a better year for investors in small cap stocks.
2017 Market Wrap-Up
Article By:
Candy Matheson
Read
Sunday, December 31, 2017 10:14 AM EDT
How the U.S. Major Indices, Major Sectors, S&P 500 Index and the SPX:VIX Ratio performed throughout 2017 and how they ended the year.
Another Solid Year For Stocks - Week In Review
Article By:
Adam Sarhan
Read
Saturday, December 30, 2017 7:22 PM EDT
The market remains very strong as investors continue to show up and buy every dip. The one BIG concern as we head into 2018 is that a lot of time has passed since we have seen a meaningful pullback or a correction of any sort.
In this article: SPX
Best Of Old School Value 2017
Article By:
Jae Jun
Read
Saturday, December 30, 2017 5:54 PM EDT
Earlier in the year, we saw Britain exercise its decision to divorce the EU. They have until March 29, 2019 to come up with the terms signed and delivered. Maybe if things don’t go as planned, 2019 will finally be the year the market gets a cold.
In this article: BITCOMP